Summary:
- University of Michigan researchers have developed a novel influenza vaccine candidate that utilizes a unique delivery mechanism to trigger a broad immune response.
- By targeting the conserved regions of the virus rather than the rapidly mutating surface proteins, the vaccine demonstrated successful cross-protection against multiple distinct flu strains in mouse models.